证券记录 · 已归档季度
APLS
Apellis Pharmaceuticals, Inc. · Healthcare · Biotechnology
16被追踪持有人
+2Δ持有人
43.69M持有股份
$756.24M报告持仓市值
+2新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +14.3% ·
股份流向 +5.2% ·
净新建仓位 +12.5%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 99 | +3 | 79.10M | $3.12B | +14 | −12 |
| Q4 2025 | 97 | +1 | 73.39M | $1.84B | +2 | — |
| Q3 2025 | 19 | +1 | 50.24M | $1.14B | +1 | −1 |
| Q2 2025 | 16 | +2 | 43.69M | $756.24M | +2 | — |
| Q1 2025 | 11 | -2 | 24.93M | $545.30M | +1 | −3 |
| Q4 2024 | 13 | +2 | 23.82M | $760.24M | +3 | −1 |
| Q3 2024 | 10 | +2 | 20.37M | $587.46M | +2 | — |
| Q2 2024 | 8 | — | 21.17M | $811.69M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 10.15M | — | $175.78M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (被动) | 10.15M | — | $175.78M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 10.15M | — | $175.78M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (被动) | 10.15M | — | $175.78M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (被动) | 10.15M | — | $175.78M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 8.98M | -27.0% | $155.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 8.98M | -27.0% | $155.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 8.98M | -27.0% | $155.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 8.98M | -27.0% | $155.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Wellington Management ✦ | 8.98M | -27.0% | $155.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (被动) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 5.98M | +46.6% | $103.45M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 5.98M | +46.6% | $103.45M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 5.98M | +46.6% | $103.45M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 5.98M | +46.6% | $103.45M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 5.98M | +46.6% | $103.45M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 33 | State Street Global Advisors ✦ (被动) | 3.56M | -9.6% | $61.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 34 | Marshall Wace ✦ | 2.70M | +11373.8% | $46.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 35 | Norges Bank ✦ (被动) | 2.37M | +50.4% | $40.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Geode Capital Management ✦ (被动) | 2.00M | +2.3% | $34.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Geode Capital Management ✦ (被动) | 2.00M | +2.3% | $34.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 442.56K | +97.5% | $7.66M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Citadel Advisors ✦ | 442.56K | +97.5% | $7.66M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | Two Sigma Investments ✦ | 406.91K | +54.8% | $7.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | D. E. Shaw & Co. ✦ | 251.07K | 新增 | $4.35M | 0.0% | New | 1 | SEC ↗ |
| 42 | Millennium Management ✦ | 202.45K | -55.2% | $3.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | Gotham Asset Management ✦ | 119.23K | +247.8% | $2.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 44 | T. Rowe Price ✦ | 92.15K | +1.6% | $1.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 19.29K | — | $333,939 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 19.29K | — | $333,939 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Renaissance Technologies ✦ | 10.99K | 新增 | $190,202 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $4.35M | 0.0% |
| Renaissance Technologies | $190,202 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 320 持有人, 137.95M 股份, $5.43B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据